Isolated extra-medullary relapse of acute leukemia following allogeneic bone marrow transplantation

Bratislava Medical Journal

Volumn 109, Issue 8, 2008, Pages 358-361

  Al Sabty, Firas ^a   Demeckova, E ^a   Bojtarova, E ^a   Czako, B ^a   Hrubisko, M ^a   Mistrik, M ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Acute leukemia; Allogeneic bone marrow transplantation; GVL effect; Isolated extra medullary relapse

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN; BREAST; CANCER INVASION; CASE REPORT; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; MIDDLE AGED; PATHOLOGY; SKIN;

ADULT; BONE MARROW TRANSPLANTATION; BRAIN; BREAST; FEMALE; GRAFT VS LEUKEMIA EFFECT; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIC INFILTRATION; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SKIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 57049176492     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
2. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factor affecting relapse and survival. Blood 1989; 74: 862-871.
3. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
4. Fefer A, Sullivan KM, Weiden P et al. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Prog Clin Biol Res 1987; 244: 401-408.
5. Byrd J, Edenfield W, Shields D, Dawson N. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.
6. Yener K, Kenneth B, David P et al. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 1999; 85: 608-615.
7. Dermime S, Mavroudis D, Jiang Y et al. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 989-999.
8. Byrd JC, Weiss RB, Arthur DC et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol 1997; 15: 466-475.
9. Blaise D, Maraninchi D, Archimbaud E et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen. Blood 1992; 79: 2578-2582.
10. Ringdén O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia. Blood 1994; 83: 2723-2730.
11. Hassan M, Ljungman P, Bolme P et al. Busulfan bioavailability. Blood 1994; 84: 2144-2150.
12. Lawson SE, Darbyshire PJ. Use of donor lymphocytes in extramedullary relapse of childhood acute lymphoblastic leukaemia following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 829-830.
13. Fleming DR, Greenwood MF, Garrison J et al. Lymphocyte infusion for delayed extramedullary relapse of acute leukemia following bone marrow transplantation. Leuk Lymphoma 1996; 21: 525-528.